Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Miossec

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Annals of the Rheumatic Diseases|December 25, 2017
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammationSophie Glatt, Dominique Baeten, Terry Baker, et al.
Arthritis Research & Therapy|December 11, 2012
Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritisErik J M Toonen, Pilar Barrera, Jaap Fransen, et al.
International Journal of Molecular Sciences|October 14, 2022
Synovial Extracellular Vesicles: Structure and Role in Synovial Fluid Tribological PerformancesLayth Ben-Trad, Constantin Ionut Matei, Mirela Maria Sava, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Frontiers in Immunology|December 10, 2021
Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid ArthritisXue-Pei Zhang, Jian-Da Ma, Ying-Qian Mo, et al.
Ageing Research Reviews|August 23, 2019
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)Emmanuel Biver, Francis Berenbaum, Ana M Valdes, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Aging Clinical and Experimental Research|January 10, 2016
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Cyrus Cooper, Thomas Bardin, Maria-Luisa Brandi, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Annals of the Rheumatic Diseases|December 25, 2017
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammationSophie Glatt, Dominique Baeten, Terry Baker, et al.
Arthritis Research & Therapy|December 11, 2012
Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritisErik J M Toonen, Pilar Barrera, Jaap Fransen, et al.
International Journal of Molecular Sciences|October 14, 2022
Synovial Extracellular Vesicles: Structure and Role in Synovial Fluid Tribological PerformancesLayth Ben-Trad, Constantin Ionut Matei, Mirela Maria Sava, et al.
Journal of Clinical Immunology|June 2, 2018
Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency PatientsBoris Bienvenu, Grégoire Cozon, Yves Mataix, et al.
Annals of the Rheumatic Diseases|April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early diseaseJosef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Frontiers in Immunology|December 10, 2021
Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid ArthritisXue-Pei Zhang, Jian-Da Ma, Ying-Qian Mo, et al.
Ageing Research Reviews|August 23, 2019
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)Emmanuel Biver, Francis Berenbaum, Ana M Valdes, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Aging Clinical and Experimental Research|January 10, 2016
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Cyrus Cooper, Thomas Bardin, Maria-Luisa Brandi, et al.
Pageof 16